Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

The FDA Has Granted Breakthrough Therapy Designation To GSK's GSK5764227, An Investigational B7-H3-Targeted Antibody-drug Conjugate Being Evaluated For Extensive-stage Small-cell Lung Cancer With Disease Progression On Or After Platinum-based Chemotherapy (Relapsed Or Refractory)

Author: Benzinga Newsdesk | August 20, 2024 06:34am

Posted In: GSK